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BeliefsAim: The purpose of this study was to document in people with type 2 diabetes (T2DM) in Barbados, atti-
tudes and beliefs that may result in psychological insulin resistance.
Methods: A representative, population-based, sample of 175 eligible people with T2DM 25 years of age
and over was surveyed by telephone. The 20-item insulin treatment appraisal scale (ITAS) was adminis-
tered (score range 20 to 100 for positive to negative perceptions).
Results: 117 people participated (67% response rate, 32% male, mean age 66 years, 90% Black, 22% on
insulin). Of non-responders, 52 were not contactable and 6 were difficult to communicate with.
Negative perceptions about insulin use included – meant a worsening of diabetes (68%), would worry
family (63%), feared self-injection (58%), meant a failure in self-management (57%), injections were pain-
ful (54%), would be seen as being sicker (46%), increased hypoglycaemia risk (38%), required effort (34%),
causes weight gain (27%), causes a deterioration in health (14%), and would have to give up enjoyable
activities (10%). Positive perceptions were – helps good glycaemic control (78%), would prevent compli-
cations (61%) and improves health (58%).
Mean total ITAS score (61.6, SD = 7.7) was lower for those on insulin compared to those not on insulin
(53.7 vs. 63.8, p < 0.0001). Sex, age and diabetes diagnosis duration were not significant predictors of
ITAS score.
Conclusions: Multiple factors related to patient beliefs and attitudes need to be considered and addressed
when initiating insulin in order to minimise psychological insulin resistance and delay. Patients using
insulin had less negative perceptions than those not on insulin.
 2017 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In people with type 2 diabetes mellitus (T2DM) good glycaemic
control helps prevent the development of complications [1]. In
many cases insulin is required to achieve good control and as
T2DM is associated with a progressive decline in pancreatic beta
cell function, the need for insulin increases with disease duration
[1]. In Barbados 28% of private compared to 15% of public sector
primary care patients with diabetes over 40 years of age are esti-
mated to be using insulin [2].Unfortunately despite the potential benefits and frequent need,
insulin initiation is often challenging and delayed for reasons that
may be related to the healthcare system [3], healthcare profes-
sional [3–7] or the patient [3,6–10]. Patient reluctance or psycho-
logical insulin resistance (PIR) has been reported to be a factor
approximately a quarter of the time [10]. Reasons include the fear
of hypoglycaemia [10,11] and painful injections [3,9,11–16], social
stigma [11,15], belief that insulin initiation means failed self-
management [8,10], their diabetes has gotten worse [3,8,10–13]
and that insulin therapy is burdensome and complex [3]. A physi-
cian’s assessment that insulin is needed does not mean that a
patient will have the same opinion or be willing to use it. Physi-
cians therefore need to determine if PIR is present and address
the causes early during diabetes management.
Exploring PIR through the framework of the theory of planned
behaviour (TPB) [17] could be potentially useful as this theory sug-
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ceived behavioural control together influence intention and ulti-
mately behaviour. Factors related to PIR may be a proxy for
behavioural intent, even though further research is needed to
explore whether behavioural intent predicts actual behaviour at
the time insulin is prescribed.
The first step to exploring this relationship would be to deter-
mine attitudes towards a behaviour in a particular context. The
insulin treatment appraisal scale (ITAS) is one way to examine
insulin-related attitudes and was created to quickly measure neg-
ative and positive beliefs regarding insulin [18]. ITAS was gener-
ated from the literature on patients’ barriers to insulin use,
discussions with health care providers and clinical encounters. It
consists of 20 questions and has a two-factor structure with items
pertaining to a positive and a negative appraisal of insulin. Snoek
and colleagues in the United States tested its reliability and validity
in a mainly Caucasian sample of both insulin naïve and insulin
treated patients with T2DM [18].
The Caribbean diaspora, a population of primarily African-
descent, extends across the world with many established commu-
nities in countries such as the USA, Canada and Europe [19]. There
is little data on the causes of PIR in this population even though
research on PIR has been focused on numerous countries and eth-
nicities [20]. A UK focus group study with 8 people of Caribbean
and 5 of African origin found that people on oral hypoglycaemic
agents felt insulin was a last resort and indicated death was immi-
nent while those on insulin thought it was efficacious and pro-
longed life [21]. Previous studies on causes of PIR have not been
conducted in Barbados or other Caribbean islands with similar
health care systems. However, cultural issues regarding insulin
have been identified among ‘ethnic minorities’ [11,13,22,23] sug-
gesting that it is important to identify such issues in all ethnicities
to allow for culturally-tailored interventions to improve insulin
uptake, compliance and patient outcomes.
Understanding the causes of PIR among people with diabetes in
Barbados, where this study was undertaken, may provide insight
that is useful to populations in other parts of the Caribbean and
in people of Caribbean descent in other parts of the world. We
therefore sought to answer the following research questions: 1)
In people with T2DM (insulin and non-insulin treated), what are
attitudes and beliefs with regards to insulin use as determined
by the ITAS? 2) What are the predictors of the total ITAS score in
this population?Material and methods
Setting
Barbados is a Caribbean island with a population of approxi-
mately 280,000 [24]. Primary care is provided by a public sector
governed by the Ministry of Health, financed through taxation
and available through 9 polyclinics located across the island, and
a private sector funded by insurance and out-of-pocket financing
by patients and available through numerous independently owned
solo or small group practices [25]. Human insulin is readily avail-
able at no cost from polyclinics or for a small dispensing fee from
private pharmacies. No public sector multidisciplinary clinics for
ongoing primary care or access to routine structured education
on diabetes are available.Participants
Participants were taken from those of the Health of the Nation
study (HotN), a population-based survey of people 25 years and
over to determine the prevalence and distribution of diabetes, car-diovascular disease and associated behavioural and biological risk
factors by age, sex and socioeconomic status. The HotN sample was
obtained by island-wide sampling of enumeration districts (EDs)
with a probability proportional to their population size. From each
ED, households were systematically selected [26]. HotN had 1234
participants, 192 (15.6%) with reported known DM [26].
Inclusion and exclusion criteria
Inclusion criteria were a history of T2DM in the HoTN study,
25 years of age and over, and the use of any form of treatment
for diabetes inclusive of lifestyle changes. Exclusion criteria
included terminal illness, institutionalisation or cognitive
impairment.
Procedure
A cross-sectional survey was conducted between July and
August of 2015. People with T2DM from the HotN sampling frame
were sent letters explaining the study and the possibility of future
telephone contact. Potential participants were then contacted by
telephone to facilitate assessment of eligibility, and once willing,
verbal consent and the interview occurred either at that time or
at the participants’ convenience.
An interviewer-administered survey consisting of patient infor-
mation (demographic data, disease duration, health sector
attended, diabetes medication, and complications of diabetes)
and the ITAS was conducted. The ITAS consists of 4 positive and
16 negative questions reflecting attitudes and beliefs towards insu-
lin, with responses on a 5-point Likert scale from strongly disagree
(a score of 1) to strongly agree (a score of 5). The scores for the pos-
itive items were reversed and added to the negative items generat-
ing a total score range of 20–100. Higher total scores indicate more
negative attitudes [18].
Data analysis
Data were entered using EpiData and imported into Stata v13
for analysis. Firstly, descriptive statistics were used to describe
variables. Then, to accommodate non-normality of data, the
Mann-Whitney test was used to compare total ITAS score and indi-
vidual ITAS items between participant subgroups, defined by
selected characteristics (sex, having complications or not, having
up to secondary level education or not, and insulin use or not).
Next, a total negative beliefs score for each participant was cre-
ated— representing the number of items to which a participant
had a negative response to an ITAS item. This number could range
from 0 to 20 (number of items on the ITAS scale).
Ethical approval
The institutional review board of the University of the West
Indies, Cave Hill, Barbados and the Barbados Ministry of Health
approved this study.
Results
Of 192 people identified as having T2DM, 17 were ineligible to
participate in this study (8 had died, 4 had mental illness, 3 had
terminal illness, 1 was hospitalised and 1 was in a nursing home).
The response rate was 67%, with 117 of 175 eligible persons partic-
ipating. Reasons for nonresponse were that 40 had telephone num-
bers not in service, 12 were not contactable after 5 attempts and 6
were difficult to communicate with over the telephone because of
hearing impairment or stroke. Non-responders had a mean age of
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characteristics were not significantly different from those of
responders (p > 0.05).
Of the 117 that participated, 80 (68%) were women, 37 (32%)
were men. The mean age was 66 (SD = 13; range: 39 to 91) years,
mean duration of T2DM was 13.5 (SD = 9; range: 1 to 34) years, 42
(36%) were married, 105 (90%) were Black, 76 (65%) completed
year 5 at secondary school and 64 (55%) were retired. Regarding
health sector attended for T2DM care, 63 (53%) received private
sector care, 38 (33%) public sector care and 16 (14%) utilized both
sectors. Regarding treatment regimen for T2DM, 13 (11%) were
assigned lifestyle changes only; 35 (30%), 39 (33%), and 4 (4%) were
on 1, 2 and 3 oral hypoglycaemic agents respectively; 15 (13%) on
insulin only; and 11 (9%) taking insulin with 1 oral hypoglycaemic
agent. Regarding complications of T2DM, 19 (16%) reported dia-
betic retinopathy, 9 (8%) neuropathy, 9 (8%) a cerebrovascular
event, 5 (4%) a myocardial infarction, and 2 (2%) nephropathy.
The mean total ITAS score was 61.6 (SD 7.7) out of a possible
range of 20 to 100. Negative attitudes and beliefs held by the
majority were that taking insulin meant their diabetes had become
much worse (68%), concerns by family and friends would increase
(63%), self- management had failed (57%), and a belief that insulin
injections were painful (54%). Other negative attitudes and beliefs
included – being seen as sicker (46%), increased hypoglycaemia
risk (38%), makes you more dependent on your doctor (38%),
requires effort (34%), it is difficult to inject the right amount of
insulin (32%), causes weight gain (27%), makes life less flexible
(24%), causes a deterioration in health (14%), and would have to
give up enjoyable activities (10%). Positive attitudes and beliefs
held by the majority included that taking insulin helps maintain
good glycaemic control (78%), would prevent complications (61%)
and improves health (58%). Participants on average had 6 negative
beliefs related to insulin (SD 3.3; range 0 to 17).
The mean total ITAS score of participants currently taking insu-
lin (53.7, 95% CI 51.1 to 56.4) was 10.1 points lower than those not
taking insulin (63.8, 95% CI 62.5 to 65.2) (p < 0.0001). Table 1
shows the responses to the 20 ITAS questions by insulin treatment
status. Participants not taking insulin were statistically signifi-
cantly more likely than those taking insulin to have the following
negative beliefs and fears about insulin – taking insulin meant that
their diabetes had become much worse [(77%, 95% CI 66 to 85) vs
(35%, 95% CI 17 to 56)] (p = 0.001), they were fearful of injecting
them self [(71%, 95% CI 59 to 79) vs (12%, 95% CI 0.02 to 30)]
(p < 0.0001), managing injections would require a lot of time and
energy [(40%, 95% CI 29 to 50) vs (15%, 95% CI 0.04 to 35)]
(p = 0.02), and taking insulin is painful [(63%, 95% CI 51 to 73) vs
(19%, 95% CI 0.07 to 39)] (p = 0.001). No other demographical fac-
tors (sex, age, sector of healthcare and duration of diabetes) signif-
icantly influenced total ITAS scores in this sample.Discussion
This study identified the factors on the ITAS that are most likely
to contribute to psychological insulin resistance in a predomi-
nantly Black Caribbean population; a population with a high preva-
lence of T2DM but little published information on the subject. Most
participants believed that insulin would increase their risk of
hypoglycaemia, and meant their diabetes had gotten worse and
they had failed to self-manage their condition. In a North American
study which included few African Americans, the negative factor
that most strongly separated people willing to use insulin from
those unwilling was the belief that beginning insulin therapy indi-
cates a failure to perform proper diabetes self-management [10]. In
an eight-nations European study, patients who were unwilling to
start insulin were more likely than willing patients to hold the neg-ative belief that starting insulin meant the disease is getting worse,
were fearful of injections and had a feeling of personal failure [8]. It
has been suggested that physicians who threaten patients with
insulin may be contributing to the belief that patients had person-
ally failed unless they make greater efforts with self-management
[27]. Many were concerned about the perceptions of important
others – family and friends would worry about them and people
would see them as sicker. All of these concerns could to some
extent be true. Most believed injecting insulin is painful, many
were afraid of injecting themselves and a third felt that managing
insulin required a lot of time and energy, and that it was difficult to
inject the right amount of insulin at the right time every day sug-
gesting a lack of perceived behavioural control (perceived ease or
difficulty in performing the required behaviour). Even with a pos-
itive attitude and intention of performing an activity a lack of per-
ceived behavioural control would be expected to decrease the
chance of the activity being performed.
Many also simultaneously held positive beliefs. Therefore, while
most felt that needing insulin meant their diabetes had gotten
worse and others would see them as sicker, the majority also felt
that insulin helped prevent the complications of diabetes,
improved health and helped maintain good blood glucose control.
Physicians counselling patients can use motivational interviewing
techniques to identify and help patients work through the oppos-
ing attitudes and beliefs for and against using insulin.
People already on insulin had a lower ITAS score than those not
on insulin, indicating that they had less negative attitudes and
beliefs. Those using insulin were less likely to feel that their dia-
betes had become much worse, that injections were painful, to
be afraid of injecting themself and feel that managing insulin injec-
tions took a lot of time and energy. This is in keeping with the find-
ings of the ITAS validation study [18] where, like this study, the
most marked difference was for people on insulin to be less fearful
of injections compared to those not on insulin. There is some evi-
dence that negative attitudes may decrease after insulin initiation
[20,28] and it is therefore possible that education and experience
may reduce negative attitudes and beliefs and improve perceived
behavioural control. However, while counselling, exposure and
desensitisation have been proposed as strategies to reduce PIR
there is a lack of studies to validate these strategies [20].
Strengths and limitations
The study design cannot determine whether experience and
education are the reasons why people already on insulin have a
lower ITAS score than those not on insulin. Reasons for refusing
insulin may have been missed by the survey instrument. Self-
reported information e.g. on disease duration, medication history
and complications may be subject to recall bias. A strength of this
study is that the HotN study [26] in which it is nested identified a
population-based sample of people with diabetes, although it is
acknowledged that as in all population based surveys of this type,
there may be unknown differences between responders and non-
responders. In the HotN Study, 55% of those eligible participated
in the study. It is not known if people with known diabetes were
more or less likely to respond. A chart audit of patients 40 years
of age and over with T2DM attending public and private clinics
in Barbados estimated that the patients had a mean age of 64 years
and 61% were female [2]. These proportions are in keeping with
this study.
Implications
These results can inform structured diabetes educational design
and counselling in Barbados. They also provide insight for health-
care professionals providing care internationally to people from
Table 1
Categorical Insulin Treatment Appraisal Scale responses of persons with diabetes in Barbados by insulin treatment status.
Item Insulin
treatment
Strongly
disagree and
disagree
n (%)
Neutral
n (%)
Strongly
agree and
agree
n (%)
1. Taking insulin means you have failed to manage your diabetes with diet and tablet No insulin
Insulin
22(24)
11(42)
14(15)
3(12)
55(61)
12(46)
2. Taking insulin means your diabetes has become much worse (p = 0.001)* No insulin
Insulin
10(11)
14(53)
11(12)
3(12)
70(77)
9(35)
3. Taking insulin helps to prevent complications of diabetes No insulin
Insulin
11(12)
1(4)
28(31)
6(23)
52(57)
19(73)
4. Taking insulin means other people see you as a sicker person No insulin
Insulin
25(27)
14(54)
20(22)
4(15)
46(51)
8(31)
5. Taking insulin makes life less flexible No insulin
Insulin
40(44)
18(70)
27(30)
4(15)
24(26)
4(15)
6. You’re afraid of injecting yourself with a needle. (p < 0.0001) No insulin
Insulin
24(27)
21(81)
2(2)
2(7)
65(71)
3(12)
7. Taking insulin increases the risk of low blood glucose levels (hypoglycaemia). No insulin
Insulin
13(14)
15(58)
39(43)
5(19)
39(43)
6(23)
8. Taking insulin helps to improve your health. No insulin
Insulin
14(16)
2(8)
27(30)
6(23)
49(54)
18(69)
9. Insulin causes weight gain. No insulin
Insulin
15(16)
10(39)
56(62)
4(15)
20(22)
12(46)
10. Managing insulin injections takes a lot of time and energy (p = 0.02) No insulin
Insulin
26(28)
21(81)
29(32)
1(4)
36(40)
4(15)
11. Taking insulin means you have to give up activities you enjoy No insulin
Insulin
63(69)
23(88)
18(20)
1(4)
10(11)
2(8)
12. Taking insulin means your health will deteriorate No insulin
Insulin
51(56)
21(81)
25(27)
4(15)
15(17)
1(4)
13. Injecting insulin is embarrassing. No insulin
Insulin
11(12)
1(4)
28(31)
6(23)
52(57)
19(73)
14. Injecting insulin is painful (p = 0.001) No insulin
Insulin
15(17)
19(73)
18(20)
2(8)
57(63)
5(19)
15. It is difficult to inject the right amount of insulin correctly at the right time every day. No insulin
Insulin
35(38)
19(73)
25(27)
1(4)
31(34)
6(23)
16. Taking insulin makes it more difficult to fulfil my responsibilities (at work or home). No insulin
Insulin
55(60)
23(88)
27(30)
1(4)
9(10)
2(8)
17. Taking insulin helps to maintain good control of blood glucose. No insulin
Insulin
4(4)
0(0)
19(21)
2(8)
67(75)
23(92)
18. Being on insulin causes family and friends to be more concerned about you. No insulin
Insulin
12(13)
8(31)
19(21)
4(15)
60(66)
14(54)
19. Taking insulin helps to improve your energy level No insulin
Insulin
8(9)
4(15)
53(58)
13(50)
30(33)
9(35)
20. Taking insulin makes you more dependent on your doctor No insulin
Insulin
22(24)
13(50)
30(33)
7(27)
39(43)
6(23)
* Bold text indicates a statistically significant difference between those taking insulin and those not taking insulin.
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tudes, perceived behavioural control (perceived personal control
over a behaviour and the frequency at which barriers are experi-
enced), and subjective norms (perceived social pressure to behave
in a certain way) need to be identified and addressed by health care
practitioners when insulin initiation is indicated, in order to min-
imise psychological insulin resistance and delay. The intention to
use or not to use insulin in many cases does not depend on a single
factor.
Interventions can involve providing correct information, help-
ing patients weigh up the pros and cons of using insulin, and help-
ing them improve confidence when perceived behavioural control
is low. A trial of insulin under medical supervision and for a short
period with the possibility of opting out has been suggested as a
way of decreasing PIR [20]. Further research is required on the
effectiveness of interventions to change not only insulin-related
beliefs and attitudes but also actual behaviour.Conflict of interest
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